Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24119683
Abstract: Beyond deficits in hippocampal-dependent episodic memory, Alzheimer’s Disease (AD) features sensory impairment in visual cognition consistent with extensive neuropathology in the retina. 12A12 is a monoclonal cleavage specific antibody (mAb) that in vivo selectively neutralizes…
read more here.
Keywords:
specific tau;
alzheimer disease;
cleavage specific;
model ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15020509
Abstract: Tau-targeted immunotherapy is a promising approach for treatment of Alzheimer’s disease (AD). Beyond cognitive decline, AD features visual deficits consistent with the manifestation of Amyloid β-protein (Aβ) plaques and neurofibrillary tangles (NFT) in the eyes…
read more here.
Keywords:
cleavage;
tau cleavage;
tau;
visuo spatial ... See more keywords